Journal of Commercial Biotechnology at #bio2012
I’m looking forward to the BIO2012 convention in Boston next week. Highlights this year: The Journal of Commercial Biotechnology will […]
I’m looking forward to the BIO2012 convention in Boston next week. Highlights this year: The Journal of Commercial Biotechnology will […]
New Exhibit Awarded Prestigious LEED® Green Building Certification(PRWeb June 13, 2012)Read the full story at http://www.prweb.com/releases/2012/6/prweb9603359.htm
Denver Zoo's Toyota Elephant Passage Exhibit is Certified Platinum Read Post »
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
ADVERTISE HERE |
This
newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Simple flat-rate |
Ultimate Plan | Premium Plan | Basic Plan | |
One year | $1,995 | $1,795 | $1,095 |
One month | $525 | $425 | $325 |
48 hours | $95 | $75 | |
Plan comparison Site tour Contact |
Drug Patent Expirations for Jun 10 2012
DrugPatentWatch Serves Your Competitive Intelligence |
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
R&D Systems, the leading supplier of bioactive proteins, is the first to offer a recombinant mouse sFRP-5. The availability of this protein is of special interest due to its potential involvement…(PRWeb June 08, 2012)Read the full story at htt…
R&D Systems Offers the First Commercially Available Recombinant… Read Post »
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
ADVERTISE HERE |
This
newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Simple flat-rate |
Ultimate Plan | Premium Plan | Basic Plan | |
One year | $1,995 | $1,795 | $1,095 |
One month | $525 | $425 | $325 |
48 hours | $95 | $75 | |
Plan comparison Site tour Contact |
Drug Patent Expirations for Jun 6 2012
DrugPatentWatch Serves Your Competitive Intelligence |
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Topricin Junior for children and the Topricin Junior “Boo Boos Happen Kit” will be featured at the 2012 PLUSH Show (The Posh Little Urbanites Show) on June 10th at the elegant Vibiana, 214 South Main…(PRWeb June 07, 2012)Read the full story at…
Topricin Junior to be Featured at the 2012 "Posh Little Urbanites… Read Post »
A study by Ohio State University found out that bug bombs are ineffective on bed bugs. For safer and more effective but affordable bed bug product, Bed Bug Bully suggested to hotel and home owners the…(PRWeb June 06, 2012)Read the full story at ht…
Study Says Bug Bombs Don't Work on Bed Bugs, Bed Bug Bully… Read Post »
Growth in the NJ veterinary market can be seen in 3 more facilities to be built by Sweetwater. The dog-friendly firm is finding fulfillment and reward in the construction of veterinary hospitals.(PRWeb June 05, 2012)Read the full story at http://www…
"Sweetwater Construction Corp. Completes its 3rd Premier… Read Post »
I’ve just published a new book by Arlen D. Meyers, MD and Courtney Price, Ph.D. The Life Science Innovation Roadmap:
New Book – The Life Science Innovation Roadmap: Getting your ideas to market Read Post »
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
ADVERTISE HERE |
This
newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Simple flat-rate |
Ultimate Plan | Premium Plan | Basic Plan | |
One year | $1,995 | $1,795 | $1,095 |
One month | $525 | $425 | $325 |
48 hours | $95 | $75 | |
Plan comparison Site tour Contact |
Drug Patent Expirations for Jun 2 2012
DrugPatentWatch Fills Your Competitive Intelligence |
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Get new actionable insights and updates from BiotechBlog